Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Stopped Accrual rate to date was too low to finish the trial in a reasonable timeframe

Conditions

• HER2-positive Breast Cancer
• Metastatic Breast Cancer
• Locally Advanced Breast Cancer
• Unresectable Breast Cancer

Interventions

• DRUG: Copanlisib
• DRUG: Trastuzumab emtansine

Sponsor

Cancer Trials Ireland